Understanding chronic kidney disease in Sub-Saharan Africa

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence, incidence, and risk factors associated with chronic kidney disease (CKD) in Sub-Saharan Africa. It will systematically enroll adult patients from the Bagamoyo district hospital and associated dispensaries, collecting comprehensive clinical, biological, lifestyle, and socioeconomic data. Participants will undergo three visits over a year to gather detailed medical histories and assess various risk factors, including cardiovascular diseases and lifestyle choices. The study seeks to fill gaps in existing data regarding CKD in this region, particularly focusing on the interactions between risk factors and kidney health over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

all adult patients (≥18 years) attending the outpatients department of the Bagamoyo district hospital (BDH) or the associated Fukayosi and Yombo dispensary

Exclusion Criteria:

* \<18 years of age
* not living in the BDH catchment area
* not of African decent
* not willing to come back for follow-up visits

Where it's running

• Bagamoyo District Hospital
  Bagamoyo, Pwani Region, Tanzania Recruiting

Study contacts

• Principal investigator: Michael Mayr, MD — University Hospital, Basel, Switzerland
• Study coordinator: Nikolai C Hodel, MSc
• Email: nikolai.hodel@swisstph.ch
• Phone: +255762768035

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lowering cholesterol and inflammation in HIV patients using Bempedoic acid

  This study is testing if a medication called Bempedoic acid can lower cholesterol and inflammation in people over 40 with HIV who have heart disease or are at risk for it.

  Recruiting at 3 sites Phase 2 University of California, San Francisco · Los Angeles, California and 2 other locations · NCT05488431

• Research on health inequality and genetic disparity in cardiovascular diseases

  This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.

  Recruiting Future Genetics Limited · Wolverhampton, West Midlands · NCT03987633

• Understanding health trends in Puerto Rico

  This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.

  Recruiting Harvard School of Public Health (HSPH) · San Juan · NCT03794531

• Investigating nutritional and environmental factors in elderly health

  This study is trying to find out how nutrition and the environment affect the health of older people living in Nanshan to help prevent diseases like high blood pressure and diabetes.

  Recruiting Sun Yat-sen University · Shenzhen, Guangdong and 1 other locations · NCT03569735

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.